Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT06487000
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT04569227
- Locations
- πΊπΈ
Lincoln Medical Center, Bronx, New York, United States
πΊπΈKent County Memorial Hospital, Warwick, Rhode Island, United States
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 63
- Registration Number
- NCT04500132
- Locations
- π°π·
Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 105
- Registration Number
- NCT03200340
- Locations
- πΊπΈ
Cancer Center of Kansas, Wichita, Kansas, United States
πΊπΈNorthShore University HealthSystem, Evanston, Illinois, United States
πΊπΈVeterans Affairs Long Beach Health Care System, Long Beach, California, United States
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 28
- Registration Number
- NCT03104595
- Locations
- π°π·
Yonsei University Health System Severance Hospital, Seoul, Korea, Republic of
π°π·National Cancer Center, Gyeonggi-do, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers
- Conditions
- Chemotherapy-Induced Neutropenia
- Interventions
- Dietary Supplement: high-fat diet
- First Posted Date
- 2016-03-07
- Last Posted Date
- 2016-03-15
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT02700360
- Locations
- π°π·
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers
- First Posted Date
- 2015-08-26
- Last Posted Date
- 2016-01-27
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 64
- Registration Number
- NCT02532712
- Locations
- π°π·
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
A Safety and PK Study of EC-18 in Healthy Subjects
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2016-01-11
- Lead Sponsor
- Enzychem Lifesciences Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT02496143
- Locations
- πΊπΈ
Carolina Phase I Clinical Research, Raleigh, North Carolina, United States